RU98120501A -
METHOD FOR ESTIMATING THE RESISTANCE OF THE RESISTIVE TREATMENT IN THE ORGANIC ARTERY POOL IN PATIENTS WITH UNCOMPENSED GLAUCOMA FORMS
- Google Patents
METHOD FOR ESTIMATING THE RESISTANCE OF THE RESISTIVE TREATMENT IN THE ORGANIC ARTERY POOL IN PATIENTS WITH UNCOMPENSED GLAUCOMA FORMS
Info
Publication number
RU98120501A
RU98120501ARU98120501/14ARU98120501ARU98120501ARU 98120501 ARU98120501 ARU 98120501ARU 98120501/14 ARU98120501/14 ARU 98120501/14ARU 98120501 ARU98120501 ARU 98120501ARU 98120501 ARU98120501 ARU 98120501A
Уфимский научно-исследовательский институт глазных болезней
Filing date
Publication date
Application filed by Уфимский научно-исследовательский институт глазных болезнейfiledCriticalУфимский научно-исследовательский институт глазных болезней
Publication of RU98120501ApublicationCriticalpatent/RU98120501A/en
Application grantedgrantedCritical
Publication of RU2173956C2publicationCriticalpatent/RU2173956C2/en
Способ оценки реактивности резистивного русла в бассейне глазничной артерии у пациентов с некомпенсированными формами глаукомы путем компрессии одноименной общей сонной артерии и оценки изменения кровотока после декомпрессии, отличающийся тем, что оценку изменения кровотока производят по глазничной артерии.A method for assessing the reactivity of the resistive bed in the orbital artery pool in patients with uncompensated forms of glaucoma by compressing the same common carotid artery and assessing changes in blood flow after decompression, characterized in that the changes in blood flow are made through the orbital artery.
RU98120501A1998-10-21Method for evaluating resistive bed reactivity in orbital artery pool in patients suffering from uncompensated glaucoma forms
RU2173956C2
(en)
Use of 2,5-dihydroxybenzenesulfone derivatives for the manufacture of drugs intended for normalization of endothelial function, for the treatment of sexual dysfunction and vascular complications in diabetes, as well as vascular disorders of
LOW-VOC GREAIFICATION AGENTS, THEIR USE IN THE PRODUCTION AND/OR TREATMENT OF LEATHER AND SKINS, AND THE CORRESPONDING PRODUCTION OR TREATMENT PROCEDURES
New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease
A method for determining the chronobiological criterion for the appointment of β-blockers in patients with arterial hypertension in combination with coronary heart disease